Pharmafile Logo
Pharmafocus logo
Advanced Search

Coronavirus forcing Eli Lilly employees to work from home

March 9, 2020
Sales and Marketing Chinese Coroanvirus, Eli Lilly, Eli Lilly Coronavirus, Wuhan Coronavirus, coronavirus

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …

News
20181130-niaid-hiv-test

Uganda finalising clinical trials on new injectable HIV drug

March 9, 2020
Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

News
nice_new_london_office_internal_3_web

NICE shoots down Dupixent for severe asthma

March 9, 2020
Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …

News
4420456374_64a3d7e6aa_75

Top Ten most popular articles on Pharmafile.com this week

March 6, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus, wuhan coronavirus.

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …

News
shutterstock

Scorpion venom added to CAR-T therapy increases efficacy in brain cancer, research shows

March 6, 2020
Medical Communications, Research and Development CAR-T, Cancer, brain cancer, glioblastoma, pharma

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

News
mental-3436232_1280

Lack of mental health treatment available for HIV patients in the UK

March 6, 2020
Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

News
az_logo

Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer

March 6, 2020
Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …

News
medications-money-cure-tablets

Indian regulators approve first drug for patients with NASH

March 6, 2020
Medical Communications FDA Approval, India, Indian Pharma, drug approval

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020
Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

News
transportation_isolation_system_1

UK cases of coronavirus hit 90 as health officials move into next phase of their response

March 5, 2020
Business Services Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

The coronavirus has continued to spread across the UK as health officials announce they have moved into the second stage …

News

China approves Roche’s Actemra to fight severe complications stemming from coronavirus

March 5, 2020
Sales and Marketing Actemra, China, Roche, coronavirus, pharma

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …

News
4972850923_170b36c774

Researchers have tested CRISPR gene editing inside a person’s body for the first time

March 5, 2020
Business Services Editas, crispr, gene editing

Allergan and Editas Medicine have treated their first patient in a clinical trial with CRISPR gene editing. This therapy is …

News
8265405611_337b629f7f_b

US prescription drug net costs rose three times faster than inflation from 2007 to 2018

March 5, 2020
Business Services Big Pharma, Trump drug prices, US Drug prices, drug prices, us drugs

The nest cost of prescription drugs rose over three times faster than the rate of inflation over the course of …

News
takeda_logo_506_small

Positive CHMP approval for Takeda’s Alunbrig in ALK+ advanced non-small lung cancer

March 4, 2020
Research and Development CHMP, EMA, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

News
chart-trading-courses-forex-preview

Big Pharma more profitable than most public firms

March 4, 2020
Research and Development Big Pharma, US Pharma, drug prices, drug regulations, regulations

Large pharmaceutical companies make a much larger profit than most other public companies, according to a new study. The research …

News
diet-pills-medication-pharmacy-sick

India reducing API exports due to coronavirus threatening global supply chain

March 4, 2020
Research and Development APIs, Active Pharmaceuticals Ingredients, Big Pharma, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …

News
nice_new_london_office_internal_3_web

NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease

March 4, 2020
Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease

UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …

News
48317770967_48ec28d656_b

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

March 4, 2020
Research and Development COVID-19, Chinese Coronavirus, Trump, Wuhan Coronavirus, coronavirus

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus …

News
pd36-1-ksc-20170808-ph_csh01_0023

MSD’s Phase 3 study of lymphoma treatment meets primary endpoints

March 3, 2020
Manufacturing and Production B-cell lymphoma, classical Hodgkin Lymphoma, lymphoma

MSD announced that its Phase 3 study of Keytruda (pembrolizumab) for the treatment of adults with relapsed or refractory classical …

News
gilead_hq_at_stockley_park_london_2

Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal

March 3, 2020
Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma

Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026